首页> 外文期刊>Pharmacology & Pharmacy >Motor Effects of 1,3-Disubstituted 8-Styrylxanthines as A1 and A2 Adenosine-Receptor Antagonists in Rats
【24h】

Motor Effects of 1,3-Disubstituted 8-Styrylxanthines as A1 and A2 Adenosine-Receptor Antagonists in Rats

机译:1,3-二取代的8-苯乙烯基黄嘌呤作为大鼠A1和A2腺苷受体拮抗剂的运动效应

获取原文
       

摘要

A series of 1,3-substituted 8-styrylxanthines (11a-d) was synthesized, under chemo- and regioselective conditions, in a good overall yield. The compounds showed affinity towards both A1 and A2A-adenosine receptors by radioligand binding by means of in vitro assays. The (E)-3-ethyl-1-propyl-8-styrylxanthine (11a) showed the greatest affinity towards the A2A receptor, whereas (E)-3-pentyl-1-propyl-8-styrylxanthine (11d) showed the greatest affinity for the A1 receptor. When the 8-styrylxanthines 11a (A15Et) and 11c (A15Bu) were administrated in rats, which were previously injured with 6-hydroxydopamine at the substantia nigra pars compacta (SNc), the turning behavior decreased 50%. Based on these results we propose to A15Et as a potential compound to treat some symptoms of Parkinson’s disease.
机译:在化学和区域选择性条件下,以良好的总收率合成了一系列的1,3-取代的8-苯乙烯基黄嘌呤(11a-d)。该化合物通过放射性配体结合通过体外测定对A1和A2A-腺苷受体均显示出亲和力。 (E)-3-乙基-1-丙基-8-苯乙烯基黄嘌呤(11a)对A2A受体的亲和力最大,而(E)-3-戊基-1-丙基-8-苯乙烯基黄嘌呤(11d)表现出最大的亲和力对A1受体的亲和力。当在大鼠中施用8-苯乙烯基黄嘌呤11a(A15Et)和11c(A15Bu)时,先前在黑质致密部(SNc)处被6-羟基多巴胺损伤,转弯行为降低了50%。基于这些结果,我们建议将A15Et用作治疗帕金森氏病某些症状的潜在化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号